CPSC recall 25223
Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
- CPSC
- unknown
- Published 2025-04-10
On 2025-04-10 the CPSC announced a recall of Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs by Kramer Laboratories Of Bridgewater New Jersey A Subsidiary Of Arcadia Consumer Healthcare Of Bridgewater New Jersey, citing the Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging….
| Agency | CPSC |
|---|---|
| Recall number | 25223 |
| Classification | Not classified |
| Status | unknown |
| Initiated | 2025-04-10 |
| Published | 2025-04-10 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Kramer Laboratories Of Bridgewater New Jersey A Subsidiary Of Arcadia Consumer Healthcare Of Bridgewater New Jersey |
| Distribution | US |
Product
Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs | This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
Reason
The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.
Source
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.